• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在改良安卡拉痘苗病毒(MVA)的ITRs中重复位点之外高效选择标记的表达

Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA).

作者信息

Abidi Sirine, Elhazaz Fernandez Aurora, Seehase Nicole, Hanisch Lina, Karlas Alexander, Sandig Volker, Jordan Ingo

机构信息

ProBioGen AG, 13086 Berlin, Germany.

Berlin Institute for Medical Systems Biology (BIMSB), 10115 Berlin, Germany.

出版信息

Vaccines (Basel). 2024 Dec 6;12(12):1377. doi: 10.3390/vaccines12121377.

DOI:10.3390/vaccines12121377
PMID:39772039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680203/
Abstract

: Poxviruses are large DNA viruses that replicate in the host cytoplasm without a nuclear phase. As vaccine vectors, they can package and express large recombinant cassettes from different positions of their genomic core region. We present a comparison between wildtype modified vaccinia Ankara (MVA) and isolate CR19, which has significantly expanded inverted terminal repeats (ITRs). With this expansion, a site in wildtype MVA, called deletion site (DS) IV, has been duplicated at both ends of the genome and now occupies an almost central position in the newly formed ITRs. : We inserted various reporter genes into this site and found that the ITRs can be used for transgene expression. However, ITRs are genomic structures that can rapidly adapt to selective pressure through transient duplication and contraction. To test the potential utility of insertions into viral telomers, we inserted a factor from the cellular innate immune system that interferes with viral replication as an example of a difficult transgene. : A site almost in the centre of the ITRs can be used for transgene expression, and both sides are mirrored into identical copies. The example of a challenging transgene, tetherin, proved to be surprisingly efficient in selecting candidate vectors against the large background of parental viruses. : Insertion of transgenes into ITRs automatically doubles the gene doses. The functionalisation of viruses with tetherin may accelerate the identification and generation of recombinant vectors for personalised medicine and pandemic preparedness.

摘要

痘病毒是大型DNA病毒,在宿主细胞质中复制,无核阶段。作为疫苗载体,它们可以从其基因组核心区域的不同位置包装和表达大型重组盒式结构。我们对野生型改良安卡拉痘苗病毒(MVA)和分离株CR19进行了比较,CR19具有显著扩展的反向末端重复序列(ITR)。通过这种扩展,野生型MVA中一个称为缺失位点IV(DS IV)的位点在基因组两端重复,现在占据了新形成的ITR中几乎中心的位置。

我们将各种报告基因插入该位点,发现ITR可用于转基因表达。然而,ITR是基因组结构,可通过瞬时重复和收缩快速适应选择压力。为了测试插入病毒端粒的潜在效用,我们插入了一种来自细胞先天免疫系统的因子,该因子干扰病毒复制,作为一个难表达转基因的例子。

ITR几乎中心的一个位点可用于转基因表达,且两侧镜像为相同拷贝。具有挑战性的转基因 tetherin的例子在从大量亲本病毒背景中筛选候选载体方面被证明出奇地有效。

将转基因插入ITR会自动使基因剂量加倍。用tetherin对病毒进行功能化可能会加速用于个性化医疗和大流行防范的重组载体的鉴定和产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/7d8eff19ce8b/vaccines-12-01377-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/a8bd3d6dfa5b/vaccines-12-01377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/7d4d4f701e7d/vaccines-12-01377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/b3688ecdbfe7/vaccines-12-01377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/97d8c9338671/vaccines-12-01377-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/fb38df49f01b/vaccines-12-01377-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/eb36a4a317bf/vaccines-12-01377-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/b8ac50c3c3e6/vaccines-12-01377-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/355e9c628082/vaccines-12-01377-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/7d8eff19ce8b/vaccines-12-01377-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/a8bd3d6dfa5b/vaccines-12-01377-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/7d4d4f701e7d/vaccines-12-01377-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/b3688ecdbfe7/vaccines-12-01377-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/97d8c9338671/vaccines-12-01377-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/fb38df49f01b/vaccines-12-01377-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/eb36a4a317bf/vaccines-12-01377-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/b8ac50c3c3e6/vaccines-12-01377-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/355e9c628082/vaccines-12-01377-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdd9/11680203/7d8eff19ce8b/vaccines-12-01377-g009.jpg

相似文献

1
Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA).在改良安卡拉痘苗病毒(MVA)的ITRs中重复位点之外高效选择标记的表达
Vaccines (Basel). 2024 Dec 6;12(12):1377. doi: 10.3390/vaccines12121377.
2
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).一种新载体株中的缺失删除位点和经蚀斑纯化的改良安卡拉痘苗病毒(MVA)的非凡基因组稳定性。
Virol Sin. 2020 Apr;35(2):212-226. doi: 10.1007/s12250-019-00176-3. Epub 2019 Dec 12.
3
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.通过基因互补策略扩大基于安卡拉痘苗病毒的改良疫苗载体的种类。
PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.
4
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.在重组改良安卡拉牛痘病毒载体中敲低转基因表达可提高遗传稳定性和多次传代过程中持续的转基因维持。
Front Immunol. 2024 Feb 6;15:1338492. doi: 10.3389/fimmu.2024.1338492. eCollection 2024.
5
Stability of the HSV-2 Gene in the del II, del III, , and - Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells.重组载体在细胞中连续传代后,单纯疱疹病毒2型基因在改良安卡拉痘苗病毒的del II、del III和 - 位点的稳定性。
Vaccines (Basel). 2020 Mar 19;8(1):137. doi: 10.3390/vaccines8010137.
6
Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.去帽酶中的自发和靶向突变增强了猴细胞中 Modified Vaccinia Virus Ankara(MVA)的复制。
J Virol. 2021 Sep 9;95(19):e0110421. doi: 10.1128/JVI.01104-21.
7
Interference with SAMHD1 Restores Late Gene Expression of Modified Vaccinia Virus Ankara in Human Dendritic Cells and Abrogates Type I Interferon Expression.干扰 SAMHD1 可恢复改良安卡拉痘苗病毒在人树突状细胞中的晚期基因表达并阻断 I 型干扰素表达。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01097-19. Print 2019 Nov 15.
8
[Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].[为获得重组改良安卡拉痘苗病毒(MVA)而设计和构建转移载体]
Rev Argent Microbiol. 2007 Jul-Sep;39(3):138-42.
9
Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.在转录去帽背景下,研究内部核糖体进入位点(IRES)插入重组痘苗病毒天坛株(MVA)基因组作为翻译增强子的情况。
PLoS One. 2015 May 26;10(5):e0127978. doi: 10.1371/journal.pone.0127978. eCollection 2015.
10
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.标记基因交换通过宿主范围选择促进重组安卡拉痘苗病毒的生产。
J Virol Methods. 2009 Mar;156(1-2):37-43. doi: 10.1016/j.jviromet.2008.10.026. Epub 2008 Dec 10.

本文引用的文献

1
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.基于病毒载体的个体化疫苗接种的 I 期临床试验引发了强烈的新抗原特异性抗肿瘤 T 细胞应答。
Clin Cancer Res. 2024 Jun 3;30(11):2412-2423. doi: 10.1158/1078-0432.CCR-23-3940.
2
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.在重组改良安卡拉牛痘病毒载体中敲低转基因表达可提高遗传稳定性和多次传代过程中持续的转基因维持。
Front Immunol. 2024 Feb 6;15:1338492. doi: 10.3389/fimmu.2024.1338492. eCollection 2024.
3
Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review.
溶瘤痘苗病毒在癌症免疫治疗中的临床前和临床试验:全面综述。
Cancer Biol Med. 2023 Aug 23;20(9):646-61. doi: 10.20892/j.issn.2095-3941.2023.0202.
4
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.高减毒痘病毒疫苗用于新发病毒性疾病。
J Mol Biol. 2023 Aug 1;435(15):168173. doi: 10.1016/j.jmb.2023.168173. Epub 2023 Jun 8.
5
Extensive ITR expansion of the 2022 Mpox virus genome through gene duplication and gene loss.广泛的 2022 猴痘病毒基因组 ITR 扩展通过基因重复和基因缺失。
Virus Genes. 2023 Aug;59(4):532-540. doi: 10.1007/s11262-023-02002-1. Epub 2023 May 31.
6
Molecular Mechanisms of Poxvirus Evolution.痘病毒进化的分子机制。
mBio. 2023 Feb 28;14(1):e0152622. doi: 10.1128/mbio.01526-22. Epub 2022 Dec 14.
7
Poxvirus under the eyes of electron microscope.电子显微镜下的痘病毒。
Appl Microsc. 2022 Nov 14;52(1):11. doi: 10.1186/s42649-022-00080-3.
8
Unique Evolution of Antiviral Tetherin in Bats.蝙蝠中抗病毒蛋白 tetherin 的独特进化。
J Virol. 2022 Oct 26;96(20):e0115222. doi: 10.1128/jvi.01152-22. Epub 2022 Sep 29.
9
Poxvirus Recombination.痘病毒重组
Pathogens. 2022 Aug 9;11(8):896. doi: 10.3390/pathogens11080896.
10
The Life Cycle of the Vaccinia Virus Genome.痘苗病毒基因组的生命周期。
Annu Rev Virol. 2022 Sep 29;9(1):239-259. doi: 10.1146/annurev-virology-091919-104752. Epub 2022 May 18.